• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconNovavax

Novavax

Robert F. Kennedy Jr. looks forward, while Donald Trump looks back at him.
FinanceModerna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’
By Sasha RogelbergMarch 31, 2025
About 47% of U.S. adults aged 50 and older said they were very or somewhat unlikely to get the new 2024–25 COVID-19 vaccine, according the University of Michigan’s National Poll on Healthy Aging.
HealthCOVID sickens older adults most severely, but less than half say they’ll get the new vaccine
By Lindsey LeakeSeptember 30, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
HealthNew COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
A Novavax scientist works in a lab
HealthA COVID-vaccine maker received $1.6 billion in Operation Warp Speed funding. It’s administered just 7,300 shots in the U.S.
By Nicholas GordonAugust 9, 2022
Novavax-lab-vaccine-covid
HealthA ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant
By Grady McGregorJuly 14, 2022
Novovax COVID-19 vaccine
HealthNovavax’s COVID-19 vaccine could finally be approved in the U.S. this month
By Lauran Neergaard and The Associated PressJune 2, 2022
Japan's Prime Minister Fumio Kishida recevies a booster shot, in March 2022
HealthNovavax stock continues its monthslong slide even after COVID vaccine earns approval in another country
By Eamon BarrettApril 19, 2022
Indian students wait in line for a COVID vaccine
HealthIndia is the first country to approve the Novavax vaccine for teens, as the world readies for another COVID wave
By Nicholas GordonMarch 23, 2022
HealthThe weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By Andrew MarquardtMarch 15, 2022
HealthSingapore is the latest country to approve Novavax’s COVID vaccine while the U.S. reviews application
By Grady McGregorFebruary 14, 2022
Sign outside Novavax Inc. headquarters in Gaithersburg, Md.
HealthNovavax’s newest approvals position it as an mRNA ‘alternative’ that health officials say may convince vaccine skeptics
By Grady McGregorFebruary 4, 2022
HealthMeet the Novastans: How Novavax vaccine’s cultlike following could alter the course of COVID
By Grady McGregorJanuary 27, 2022
HealthNovavax’s COVID-19 vaccine gains momentum with Australia approval
By Grady McGregorJanuary 19, 2022
Novavax CEO Stanley Erck
HealthWhen will Novavax’s vaccine be ready? CEO Stanley Erck says 10 countries may approve its COVID shot in next 90 days
By Grady McGregorJanuary 11, 2022
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
FinanceOmicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By Jeremy KahnDecember 29, 2021
1
  • 1
  • 2
2
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.